Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Avoid nerves and blood vessels during IM injection
A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder
Funding This work was supported by The Key R&D Projects of Science and Technology Department of Sichuan Province (Grant No
Before peptides, only two FDA-approved treatments existed: Vyleesi (PT-141, approved 2019) and Addyi (flibanserin, approved 2015)
US$ 21.41
US$ 26.50
US$ 25.87
US$ 24.59
US$ 28.25
US$ 24.12
US$ 22.76
US$ 23.83
US$ 20.28
US$ 20.52
US$ 22.65
US$ 21.61
